Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride |
| |
Authors: | Hussein O Ammar H A Salama M Ghorab A A Mahmoud |
| |
Institution: | (1) Department of Pharmaceutical Technology, National Research Center, Dokki, Cairo, Egypt;(2) Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt |
| |
Abstract: | Dilutable nanoemulsions are potent drug delivery vehicles for ophthalmic use due to their numerous advantages as sustained
effect and high ability of drug penetration into the deeper layers of the ocular structure and the aqueous humor. The aim
of this article was to formulate the antiglaucoma drug dorzolamide hydrochloride as ocular nanoemulsion of high therapeutic
efficacy and prolonged effect. Thirty-six systems consisting of different oils, surfactants, and cosurfactants were prepared
and their pseudoternary-phase diagrams were constructed by water titration method. Seventeen dorzolamide hydrochloride nanoemulsions
were prepared and evaluated for their physicochemical and drug release properties. These nanoemulsions showed acceptable physicochemical
properties and exhibited slow drug release. Draize rabbit eye irritation test and histological examination were carried out
for those preparations exhibiting superior properties and revealed that they were nonirritant. Biological evaluation of dorzolamide
hydrochloride nanoemulsions on normotensive albino rabbits indicated that these products had higher therapeutic efficacy,
faster onset of action, and prolonged effect relative to either drug solution or the market product. Formulation of dorzolamide
hydrochloride in a nanoemulsion form offers, thus, a more intensive treatment of glaucoma, a decrease in the number of applications
per day, and a better patient compliance compared to conventional eye drops. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|